关键词：葡萄膜炎；炎症；虹膜；脉络膜；睫状体；感染；损伤；自身免疫性疾病
摘 要：Uveitis is defined as the inflammation of the middle layer of the eye i.e. the uvea, also known as the uceal tract. The uvea consists of the iris, choroid and ciliary body. Infections, injury and autoimmune disorders may be related to the development of uveitis, however the exact cause is often unknown. Various types of uveitis are: anterior uveitis, intermediate uveitis, posterior uveitis, and pan uveitis. The most common type of uveitis is an inflammation of the iris called iritis (anterior uveitis). Uveitis can be serious, leading to permanent vision loss.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Product Profiles

05. Market Research Methodology

05.1 Market Research Process

05.2 Research Methodology

06. Introduction

07. Market Landscape

07.1 Market Overview

07.2 Market Size and Forecast

07.3 Five Forces Analysis

08. Treatment Options for Uveitis

09. Pipeline Snapshot

10. Rate of Incidence and Prevalence

10.1.1 US

10.1.2 Europe

11. Geographical Segmentation

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

19.1 Competitive Scenario

19.1.1 Key News

19.1.2 Mergers and Acquisitions

19.2 Market Share Analysis 2013

19.3 Future Vendors Expected to Tap the Market

20. Key Vendor Analysis

20.1 AbbVie Inc.

20.1.1 Key Facts

20.1.2 Business Description

20.1.3 Product Segmentation

20.1.4 Revenue by Product Line

20.1.5 Revenue Comparison 2012 and 2013

20.1.6 Revenue by Geographical Segmentation

20.1.7 Business Strategy

20.1.8 Key Developments

20.1.9 SWOT Analysis

20.1.10 Strengths

20.1.11 Weaknesses

20.1.12 Opportunities

20.1.13 Threats

20.2 Alcon Inc.

20.2.1 Key Facts

20.2.2 Business Description

20.2.3 Business Segmentation

20.2.4 Revenue by Business Segmentation

20.2.5 Revenue Comparison 2012 and 2013

20.2.6 Revenue by Geographical Segmentation

20.2.7 Business Strategy

20.2.8 Key Developments

20.2.9 SWOT Analysis

20.2.10 Strengths

20.2.11 Weaknesses

20.2.12 Opportunities

20.2.13 Threats

20.3 Allergan Inc.

20.3.1 Key Facts

20.3.2 Business Description

20.3.3 Business Segmentation

20.3.4 Revenue by Business Segmentation

20.3.5 Revenue Comparison 2011-2013

20.3.6 Revenue by Geographical Segmentation

20.3.7 Business Strategy

20.3.8 Key Developments

20.3.9 SWOT Analysis

20.3.10 Strengths

20.3.11 Weaknesses

20.3.12 Opportunities

20.3.13 Threats

20.4 Bausch & Lomb Inc.

20.4.1 Key Facts

20.4.2 Business Description

20.4.3 Key Product Categories

20.4.4 Business Strategy

20.4.5 Key Developments

20.4.6 SWOT Analysis

20.4.7 Strengths

20.4.8 Weaknesses

20.4.9 Opportunities

20.4.10 Threats

21. Other Reports in this Series